180 related articles for article (PubMed ID: 9583684)
21. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S
Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways.
Fielding CA; Sandvej K; Mehl A; Brennan P; Jones M; Rowe M
J Virol; 2001 Oct; 75(19):9129-41. PubMed ID: 11533177
[TBL] [Abstract][Full Text] [Related]
23. Epstein-barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2.
Wakisaka N; Murono S; Yoshizaki T; Furukawa M; Pagano JS
Cancer Res; 2002 Nov; 62(21):6337-44. PubMed ID: 12414666
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9.
Stevenson D; Charalambous C; Wilson JB
Cancer Res; 2005 Oct; 65(19):8826-35. PubMed ID: 16204053
[TBL] [Abstract][Full Text] [Related]
25. [Effect of Epstein-Barr virus latent membrane protein 1 (LMP1) on apoptosis of nasopharyngeal carcinoma cell line CNE1].
Chen Y; Chen XY
Ai Zheng; 2002 May; 21(5):498-503. PubMed ID: 12452040
[TBL] [Abstract][Full Text] [Related]
26. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
Ho CH; Chen CL; Li WY; Chen CJ
Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
[TBL] [Abstract][Full Text] [Related]
27. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
[TBL] [Abstract][Full Text] [Related]
28. Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.
Dirmeier U; Neuhierl B; Kilger E; Reisbach G; Sandberg ML; Hammerschmidt W
Cancer Res; 2003 Jun; 63(11):2982-9. PubMed ID: 12782607
[TBL] [Abstract][Full Text] [Related]
29. The EBV transforming protein, latent membrane protein 1, mimics and cooperates with CD40 signaling in B lymphocytes.
Busch LK; Bishop GA
J Immunol; 1999 Mar; 162(5):2555-61. PubMed ID: 10072495
[TBL] [Abstract][Full Text] [Related]
30. [DNA cloning and partial sequence analysis of EBV LMP1 gene isolated from human nasopharyngeal carcinoma cell line SUNE1].
Chen Y; Guo H; Cao H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Sep; 13(3):217-21. PubMed ID: 12569749
[TBL] [Abstract][Full Text] [Related]
31. Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1.
Thompson MP; Aggarwal BB; Shishodia S; Estrov Z; Kurzrock R
Leukemia; 2003 Nov; 17(11):2196-201. PubMed ID: 14523478
[TBL] [Abstract][Full Text] [Related]
32. Biological properties of TW01 cells expressing latent membrane protein-1 gene of EBV-derived from nasopharyngeal carcinoma cells at different stages of malignancy.
Tan EL; Sam CK
Exp Oncol; 2007 Sep; 29(3):166-74. PubMed ID: 18004239
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation.
Miller WE; Mosialos G; Kieff E; Raab-Traub N
J Virol; 1997 Jan; 71(1):586-94. PubMed ID: 8985387
[TBL] [Abstract][Full Text] [Related]
34. [Effects of two LMP1 variants on resistance of CNE1 cell strain to TGF-beta1].
Huang H; Huang PC
Ai Zheng; 2003 Dec; 22(12):1254-9. PubMed ID: 14693046
[TBL] [Abstract][Full Text] [Related]
35. [Construction and function analysis of a CTAR-2 region mutant of the Epstein-Barr virus-encoded latent membrane protein-1].
He ZM; Chen ZC
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Mar; 35(3):261-5. PubMed ID: 12621551
[TBL] [Abstract][Full Text] [Related]
36. Induction of inducible nitric oxide synthase by Epstein-Barr virus B95-8-derived LMP1 in Balb/3T3 cells promotes stress-induced cell death and impairs LMP1-mediated transformation.
Yu JS; Tsai HC; Wu CC; Weng LP; Li HP; Chung PJ; Chang YS
Oncogene; 2002 Nov; 21(52):8047-61. PubMed ID: 12439755
[TBL] [Abstract][Full Text] [Related]
37. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes.
Thornburg NJ; Raab-Traub N
J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446
[TBL] [Abstract][Full Text] [Related]
38. Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma.
Yoshizaki T; Horikawa T; Qing-Chun R; Wakisaka N; Takeshita H; Sheen TS; Lee SY; Sato H; Furukawa M
Clin Cancer Res; 2001 Jul; 7(7):1946-51. PubMed ID: 11448908
[TBL] [Abstract][Full Text] [Related]
39. Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells.
Man C; Rosa J; Lee LT; Lee VH; Chow BK; Lo KW; Doxsey S; Wu ZG; Kwong YL; Jin DY; Cheung AL; Tsao SW
Oncogene; 2007 May; 26(21):3069-80. PubMed ID: 17099724
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
